BRPI0510858A - composition, compound and method for administering a biologically active agent to an animal requiring the same - Google Patents

composition, compound and method for administering a biologically active agent to an animal requiring the same

Info

Publication number
BRPI0510858A
BRPI0510858A BRPI0510858-6A BRPI0510858A BRPI0510858A BR PI0510858 A BRPI0510858 A BR PI0510858A BR PI0510858 A BRPI0510858 A BR PI0510858A BR PI0510858 A BRPI0510858 A BR PI0510858A
Authority
BR
Brazil
Prior art keywords
administering
compound
composition
active agent
biologically active
Prior art date
Application number
BRPI0510858-6A
Other languages
Portuguese (pt)
Inventor
Maria Isabel Gomez-Orellana
David Gschneidner
Andrea Leone-Bay
Destardi Moye-Sherman
Stephen V Pusztay
Parshuram Rath
Pingwah Tang
John J Weidner
Jianfeng Song
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Priority claimed from PCT/US2005/017309 external-priority patent/WO2005112633A2/en
Publication of BRPI0510858A publication Critical patent/BRPI0510858A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO, COMPOSTO E MéTODO PARA ADMINISTRAR UM AGENTE BIOLOGICAMENTE ATIVO A UM ANIMAL NECESSITANDO O MESMO Compostos e composições para a liberação de agentes ativos são providos. Métodos de aministração e preparação são providos também.COMPOSITION, COMPOUND, AND METHOD FOR ADMINISTERING A BIOLOGICALLY ACTIVE AGENT NEEDING ANIMAL Compounds and compositions for the release of active agents are provided. Administration and preparation methods are provided as well.

BRPI0510858-6A 2004-05-14 2005-05-16 composition, compound and method for administering a biologically active agent to an animal requiring the same BRPI0510858A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US57105504P 2004-05-14 2004-05-14
US57109004P 2004-05-14 2004-05-14
US57109204P 2004-05-14 2004-05-14
US57108904P 2004-05-14 2004-05-14
US57119504P 2004-05-14 2004-05-14
US57115104P 2004-05-14 2004-05-14
US57131504P 2004-05-14 2004-05-14
US57114404P 2004-05-14 2004-05-14
US57109304P 2004-05-14 2004-05-14
US57119404P 2004-05-14 2004-05-14
PCT/US2005/017309 WO2005112633A2 (en) 2004-05-14 2005-05-16 Compounds and compositions for delivering active agents

Publications (1)

Publication Number Publication Date
BRPI0510858A true BRPI0510858A (en) 2007-12-26

Family

ID=38829399

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510858-6A BRPI0510858A (en) 2004-05-14 2005-05-16 composition, compound and method for administering a biologically active agent to an animal requiring the same

Country Status (1)

Country Link
BR (1) BRPI0510858A (en)

Similar Documents

Publication Publication Date Title
BR0008590A (en) Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
BR0207871A (en) Composition for releasing bisphosphonate for a target
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
BR0112311A (en) Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use
BR0114799A (en) Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents
RS52169B (en) Stable laquinimod preparations
BRPI0606318A2 (en) compound, composition, and use of a compound
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
EP2349279A4 (en) Modulators of aldehyde dehydrogenase and methods of use thereof
EA200700501A1 (en) COMPOSITION (OPTIONS) AND METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE PROCESSES, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF OBTAINING SOLID DISPERSION OF THE SUBSTANCE
BR0207872A (en) Active agent release compound, composition, unit dosage form and method of administration
EA201000436A1 (en) STEROID [3,2-С] PYRAZOLIC COMPOUNDS WITH GLUCOCORTICOID ACTIVITY
BR0214199A (en) Phenoxy amine compositions to release active agents, dosage unit form and method of administration
EA200970532A1 (en) FUMARATE SALT (ALPHA S, BETA R) -6-BRUM-ALPHA- [2- (DIMETHYLAMINO) ETHYL] -2-METHOXY-ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-HINOLINETHANOL
DK1885187T3 (en) Method of Treating Drug-Resistant Cancer
EA200702593A1 (en) HIGHLY CONCENTRATED COMPOSITIONS APPLICABLE FOR THE FIGHT AGAINST ECO AND END-PARASITES
AR047993A1 (en) PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES
AR109263A2 (en) COMPOSITION INCLUDING MOXIDECTINE
WO2005112633A3 (en) Compounds and compositions for delivering active agents
SE0302546D0 (en) New compounds
BRPI0516077A (en) antimicrobial compositions comprising a natural agent selected from gallic acid, eucalipotol, naringin, a jasminic acid compound and any combination thereof
CL2009001267A1 (en) Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
SE0402635D0 (en) Chemical compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.